OR WAIT null SECS
June 30, 2022
Ipsen will acquire Epizyme, who recently had their lead medicine Tazverik (tazemetostat) approved by FDA for treatment of relapsed or refractory follicular lymphoma.
June 27, 2022
ImmunoGen has formed a research collaboration with Oxford BioTherapeutics to develop novel antibody-drug conjugates for cancers with high unmet needs.
Lonza will produce drug product for Pierre Fabre’s monoclonal antibody W0180.
The partnership between Echosens and Novo Nordisk is intended to increase awareness and early diagnosis of non-alcoholic steatohepatitis (NASH).
June 22, 2022
Kindeva’s acquisition of iPharma will increase the company’s inhalation formulation outsourcing capabilities.
June 17, 2022
Humanigen and PCI Pharma Servicesare partnering up for the commercialization of lenzilumab.
Merck has entered into a collaboration with Agilent Technologies with the aim of filling the industry gap in PAT for downstream processing.
Exothera, LogicBioTherapeutics, and Polyplus-transfection, are collaborating on the development of a scalable AAV manufacturing platform.
June 13, 2022
The deal will see Spectrum market and distribute ANGUS’ biologics grade buffers in the United States and Canada.
June 09, 2022
Following the acquisition by Altaris Capital Partners, Johnson Matthey Health has rebranded as Veranova.